Cataract
Conditions
Keywords
Cataract
Brief summary
The goal of this prospective cohort study is to compare visual quality after cataract surgery in patients implanted with a new domestic trifocal intraocular lens (D615L) versus the Zeiss AT LISA tri 839MP. The main question it aims to answer is: Is the uncorrected distance, intermediate, and near visual acuity achieved with D615L non-inferior or superior to that achieved with the Zeiss 839MP? Participants diagnosed with age-related cataract will undergo phacoemulsification and receive one of the two intraocular lenses. They will attend follow-up visits where uncorrected visual acuity, defocus curves, and the VF-14 questionnaire will be assessed over a follow-up period of at least 6 months.
Interventions
implanted D615L
Sponsors
Study design
Eligibility
Inclusion criteria
* diagnosed age-related cataract; * preoperative corneal astigmatism \<1.0 D; * endothelial cell count \>2000/mm²; * signed informed consent and ability to complete 6-month follow-up
Exclusion criteria
* prior corneal refractive, glaucoma or vitreoretinal surgery; * intraoperative posterior capsule rupture, zonular dehiscence or vitreous loss; * corneal pathology, macular edema or optic neuropathy affecting visual assessment; * active ocular inflammation, glaucoma, maculopathy or diabetic retinopathy; * uncontrolled systemic disease such as diabetes or autoimmune disorders.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| UIVA | From enrollment to the end of treatment at 6 months | uncorrected-intermediate visual acuity |
Countries
China